Shimozaki Keitaro, Nakayama Izuma, Takahari Daisuke
Dept. of Gastroenterological Chemotherapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research.
Gan To Kagaku Ryoho. 2021 Aug;48(8):1000-1006.
The SARS-CoV-2 was first identified in December 2019 in Wuhan, China. Since then, the ongoing COVID-19 pandemic has drastically changed the healthcare system, including cancer treatments worldwide. Since March 2020 in Japan, cancer patients faced a crisis; they suffered from delays or restrictions in cancer treatment during the initial outbreak. At present, we can perform cancer treatment as usual. Most of the treatments depend on continuous infection control by cancer patients and their families. However, the need to recognize cancer treatment management during the COVID-19 pandemic is crucial. Cancer treatment practice, purpose, risk factors, and the evidence during clinical trials should be comprehensively evaluated and adapted for each patient. Moreover, there is a need to discuss care planning between healthcare professionals, patients, and their families in advance. The COVID-19 vaccine could be essential for cancer patients. In this article, we review cancer treatment points for implementing whole-person care, including advanced care planning for patients with gastrointestinal malignancies, during the COVID-19 pandemic.
严重急性呼吸综合征冠状病毒2（SARS-CoV-2）于2019年12月在中国武汉首次被发现。自那时以来，持续的新型冠状病毒肺炎（COVID-19）大流行极大地改变了医疗系统，包括全球范围内的癌症治疗。自2020年3月起在日本，癌症患者面临危机；在疫情最初爆发期间，他们的癌症治疗出现延误或受到限制。目前，我们可以照常进行癌症治疗。大多数治疗依赖于癌症患者及其家属持续的感染防控。然而，在COVID-19大流行期间认识癌症治疗管理的必要性至关重要。癌症治疗的实践、目的、风险因素以及临床试验期间的证据都应针对每位患者进行全面评估并加以调整。此外，有必要提前在医疗专业人员、患者及其家属之间讨论护理计划。COVID-19疫苗对癌症患者可能至关重要。在本文中，我们回顾了在COVID-19大流行期间实施全人护理的癌症治疗要点，包括为胃肠道恶性肿瘤患者制定的临终关怀计划。
